Trial intelligence / Profile preview

Optimal Inspiratory Pressure for Facemask Pressure-controlled Ventilation in Children

NCT02471521Completed

Sponsor
Seoul National University Hospital
Start
Feb 2015
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of rocuronium (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Inspiratory Pressure That Cause Gastric Insufflation. Started Feb 2015; status: completed.

02

Drugs

rocuronium

Beyond the preview

Go deeper on NCT02471521.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02471521.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call